Preservation of β-cell function in type 2 diabetes by GLP-1 based therapy / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
;
(12): 附录6a-5, 2008.
Artigo
em Chinês
| WPRIM
| ID: wpr-597353
ABSTRACT
Type 2 diabetes is characterized by deteriorated β-cell function and progressive loss of β-cell mass. Pancreatic islets are a target of high concentrations of glucose, pro-inflammatory cytokines and free fatty acid levels, which are associated with obesity, insulin resistance and β-cell apeptosis. Therapy targeting β-cell dysfunction is crucial in the treatment of type 2 diabetes. GLP-1, one of the incretin hormones, has been demonstrated to improve glycaemic control and β-cell function through its multiple physiological effects. In this review, the mechanisms involved in β-cell dysfunction and β-cell loss are addressed, and the updates in GLP-1 based therapy for the preservation of β-cell mass and β-cell function in type 2 diabetes are also reviewed.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Chinese Journal of Endocrinology and Metabolism
Ano de publicação:
2008
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS